Breakpoints

Latest Episodes:

#14 – Pumpkin-Spiced Lessons: Phages, Posters, and Paul Sax Nov 08, 2019

Show notes

Erin McCreary (@erinmccreary) and Ryan Shields (@ryankshields) are joined by Dr. Paul Sax (@PaulSaxMD) to review important updates in HIV care from IDWeek 2019. They also go “rapid fire” through posters and oral abstracts presented at IDWeek 2019, nerd out over genomics, phages, and beta-lactamases, and discuss the new CAP and vancomycin guidelines.

Learn more about the Society of Infectious Diseases Pharmacists: https://sidp.org/About Twitter: @SIDPharm (https://twitter.com/SIDPharm) Instagram: @SIDPharm (https://www.instagram.com/sidpharm/) Facebook: https://www.facebook.com/sidprx LinkedIn: https://www.linkedin.com/company/sidp/

#13 – Provocative Titles and Pro-Con Debates Nov 08, 2019

Show notes

Erin McCreary (@erinmccreary) and Ryan Shields (@ryankshields) discuss the IDWeek 2019 session "We're Part of the Problem: How ID Killed Antibiotic Development' and other hot topics including pro-con debates, behavioral approaches to antimicrobial stewardship, and more.

#12 – Late Breaker Trials and #WhyIVaccinate Nov 01, 2019

Show notes

Erin McCreary (@erinmccreary) and Ryan Shields (@ryankshields) share some big announcements from IDWeek 2019 including the #WhyIVaccinate movement, data from late-breaking clinical trials, new partnerships, and more!

#11 – Practice-changing Publications ft. David van Duin Nov 01, 2019

Show notes

Erin McCreary (@erinmccreary) and Ryan Shields (@ryankshields) are joined by Dr. David van Duin (@davidvanduin) to review “Clinical Trials That Might Change Your Practice” in bacteriology, virology, and mycology from IDWeek 2019.

#10 – So You're an Antimicrobial Steward... Now What? Jul 31, 2019

Show notes

Host Erin McCreary (@erinmccreary) and expert panelists Libby Dodds Ashley (@The_Real_LDA), Lisa Dumkow (@LisaIDpharmD), and Jamie Kisgen (@KisgenUF) share real-world experiences in order to empower new (and existing) practitioners as antimicrobial stewardship leaders. Find out how to get started based on different training and work environments, develop relationships with key players, and address the importance of “big picture” goal setting within stewardship programs. Listen and learn (and get ready for some great stories!)

#9 – Show Me the Data! Jul 31, 2019

Show notes

Host Erin McCreary (@erinmccreary) and expert panelists Libby Dodds Ashley (@The_Real_LDA), Lisa Dumkow (@LisaIDpharmD), and Jamie Kisgen (@KisgenUF) discuss how to market your stewardship program, with an emphasis on generating meaningful data to sustain and expand your program. Panelists share how they balance day-to-day activities with moving big projects forward, leveraging learners, presenting to the C-suite, and more.

#8 – Stewardship is a Team Sport Jul 31, 2019

Show notes

Journey with host Erin McCreary (@erinmccreary) and expert panelists Libby Dodds Ashley (@The_Real_LDA), Lisa Dumkow (@LisaIDpharmD), and Jamie Kisgen (@KisgenUF) through their lessons learned and favorite moments of their stewardship careers. We describe how to evolve as a stewardship team member and leader, enhance collaborations, promote culture change, and give and receive feedback.

#7 – Rapid Fire Data from ECCMID 2019 Jul 10, 2019

Show notes

Erin McCreary (@erinmccreary) and Ryan Shields (@ryankshields) go “rapid fire” through posters and oral abstracts presented at ECCMID 2019, including: rapid diagnostics, the influence of leadership in antimicrobial stewardship, iPad technology and patient’s beliefs about antibiotics, imipenem-relebactam, cefiderocol, rezafungin, ibrexafungerp, sulbactam-ETX2514, iclaprim, lefamulin, and tebipenem.

#6 – Tazobactam and Tulips: Hot Topics from ECCMID 2019 Jul 10, 2019

Show notes

Erin McCreary (@erinmccreary) and Ryan Shields (@ryankshields) review expanded MERINO trial data including mortality by pathogen MIC, PK-PD principles, BLING III, beta-lactam therapeutic drug monitoring, linezolid dosing in renal impairment, microbiology issues, and updates from EUCAST.

CORRECTION: Piperacillin-tazobactam was dosed 4.5g IV every 6 hours in the Merino trial.

#5 – Nerding Out at ECCMID 2019 Jul 10, 2019

Show notes

Erin McCreary (@erinmccreary) and Ryan Shields (@ryankshields) share their secret passions and nerdiest moments from ECCMID 2019, including multi-omics data for Pseudomonas aeruginosa, the effects of chemotherapy on antimicrobial resistance, phage therapy, and more!

Our TOPPODCAST Picks

Follow Us

Stay Connected

Related Podcasts

Links

Stay Connected